-
1
-
2
-
3
-
4
-
5
-
6
Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
Gepubliceerd in 2025Onderwerpen: -
7
Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
Gepubliceerd in 2025Onderwerpen: -
8
Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
Gepubliceerd in 2025Onderwerpen: -
9
Table S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
Gepubliceerd in 2025Onderwerpen: -
10
Table S4 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
Gepubliceerd in 2025Onderwerpen: -
11
Table S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
Gepubliceerd in 2025Onderwerpen: -
12
Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Gepubliceerd in 2025Onderwerpen: -
13
Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Gepubliceerd in 2025Onderwerpen: -
14
Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Gepubliceerd in 2025Onderwerpen: -
15
Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Gepubliceerd in 2025Onderwerpen: -
16
Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Gepubliceerd in 2025Onderwerpen: -
17
-
18
-
19
-
20